11/1/2022Pharmaniaga Partners JD.com to Enter China Healthcare Market

11/1/2022Invincible Diabetes Turns APAC Into Pharma Goldmine (BioSpectrum)

11/1/2022China Bars Celebrities from Endorsing Products to Boost 'Traditional V...

10/31/2022Yes! It's Now Time to Reconfigure Your China Business Model Again

10/31/2022Big Pharma Dominated the Deals Space in September (PharmaDJ)

10/31/2022Financial-related Company News Digest (October 2022)

10/31/2022Novartis Abandons US PD-1 Submission Plan for Tislelizumab

10/31/2022NMPA Suspends Import, Sales and Use of GSK's Prostate Cancer Drug Avod...

10/31/2022JPO Bans GSK from Participating in China's National Level Centralized ...

10/30/2022Ascletis Pharma Ends Down After Pfizer Supply Deal Sent Stock Soaring

10/28/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (64...

10/28/2022Recent Executive Moves

10/28/2022Drug R&D and Product Registration News Digest October 2022 (3)

10/28/2022XtalPi Announces Research Collaboration with Janssen

10/27/2022NMPA Announces Package Insert Revision of Domperidone Formulations

10/27/2022CDE Solicits Comments on Draft Work Standards for Review of Drug Clini...

10/27/2022Salubris and Anlong Bio Enter Partnership for Small Nucleic Acid Dru...

10/27/2022China NMPA Approval Tracker 09/2022 (PharmaDJ)

10/27/2022Semiconductor Export Curbs Hitting China To Be Followed By Biotech and...

10/26/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...

10/26/2022NMPA Issues the Measures for the Administration of Drug Recalls (with ...

10/26/2022WuXi Bio Launches 48,000L Commercial Drug Substance Manufacturing Faci...

10/25/2022CDE Solicits Comments on Draft Technical Guidelines For Clinical Trial...

10/25/2022CDE Solicits Comments on Draft Technical Guidelines for Pharmaceutical...

10/25/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Safet...

10/25/2022Crisis or Opportunity? Biotech Companies Are at A Crossroads in The St...

10/25/2022Clinical Research Opportunities in China and the Path to USFDA Approva...

10/24/2022U.S. Government Seeks to Restrict Biotechnology Cooperation with China...

10/24/2022NASDAQ-listed BIMI Disposes Acquired Chinese Pharma Distributor

10/21/2022CDE Solicits Comments on Draft Provisions for GLP Certification of Dru...

Page:124/775 Total number of articles:23243: [First][<<] [122] [123] [124] [125] [126] [>>] [End]